Sanofi, TB Alliance to collaborate on tuberculosis drugs
NEW YORK — French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development to develop drugs for tuberculosis.
The drug maker and the TB Alliance said the deal will include discovery and development of new drug compounds for the disease, which caused almost 1.5 million deaths globally and affected nearly 9 million in 2010, according to the World Health Organization.
Under the agreement, the two will work on several new compounds in Sanofi’s library that have shown effectiveness against the bacterium that causes TB, known as Mycobacterium tuberculosis. This will include in-depth research of lead compounds and the chemical optimization of compounds that have been identified as hits through high-throughput screening.
Alliance Boots acquires stake in Chinese wholesale market
LONDON — Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million. On completion of the transaction, which is subject to various regulatory approvals, Alliance Boots will be the second largest shareholder in Nanjing Pharmaceutical with board and operational management representation.
"This agreement builds on the success we have already had in China and further strengthens our commitment to the country as well as our willingness to play an active role in the evolution of the market in partnership with the authorities and key players," Alliance Boots executive chairman Stefano Pessina said. "We believe that this strategic investment marks an important step in our long-term development in Asia.”
"By introducing Alliance Boots advanced supply chain management technology and experience, Nanjing Pharmaceutical will be able to improve its management practices, achieve greater performance and help China’s medical industry reach global standards, as well as support the pharmaceutical sector in establishing a vibrant social responsibility," Nanjing chairman Zhou Yaoping said.
Nanjing Pharmaceutical, which is listed on the Shanghai Stock Exchange, is the fifth-largest pharmaceutical wholesaler in China with sales of around $3.2 billion in 2011.
Alliance Boots first entered the Chinese pharmaceutical distribution market in 2008 through its Guangzhou Pharmaceuticals Corporation joint venture, which operates in complementary geographies.
Supervalu names new chief information officer
MINNEAPOLIS — Supervalu on Thursday announced the appointment of Kathy Persian as SVP and chief information officer. Persian, 45, joined the company in February 2010 in the role of group VP retail and merchandising systems, and later moved to group VP corporate planning, analysis and business process.
Persian was named to the CIO post following the decision by Wayne Shurts to accept a position with another company, Supervalu reported. In her new role as chief information officer, Persian will lead all of the company’s information technology activities.
“Kathy has held roles within Supervalu that have allowed her to become familiar with both the business and information technology sides of the company,” stated Wayne Sales, Supervalu president, CEO and chairman. “This experience will serve her well in providing the technological and business support the company needs as we continue to focus on profitable growth while reducing expenses.”
Prior to Supervalu, Persian spent more than 20 years at Accenture and Best Buy working in business areas of IT, general retail, retail operations, merchandising, supply chain and finance. At Accenture, Persian began as a staff consultant and worked her way up to a partner in their retail practice. She most recently worked for Best Buy as the SVP international business process and operations.